Pardeep Nijhawan, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 7,000 shares at $3.18 ($22K) on 2022-03-11, disclosed to the SEC on 2022-03-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.06 | 5,000 | $15K | 70.6% |
| 2 | $3.18 | 2,000 | $6K | 29.4% |
| Total | $3.09 avg | 7,000 | $22K | 100% |
| Filing → |
| EDSA | BUY | 2026-03-05 | $43K | — | Filing → |
| EDSA | BUY | 2026-03-04 | $36K | — | Filing → |
| EDSA | BUY | 2026-03-03 | $6K | — | Filing → |